• If you are wondering whether Aramark’s current share price reflects its true value, the next sections walk through what the numbers actually say about the stock.
• Aramark shares last closed at US$44.95, with returns of 5.6% over 30 days, 22.9% year to date and 35.2% over 1 year, which has many investors reassessing both its potential and its risks.
• Over the past year Aramark has been in the spotlight as investors have tracked its performance and repositioned their expectations for the business. These shifts in sentiment help explain why the stock has delivered 73.4% over 5 years and 85.3% over 3 years.
• Despite this track record, Aramark currently has a valuation score of 1/6. The discussion ahead will compare different valuation approaches and then finish with a broader way to think about what the current price really means.

Aramark scores just 1/6 on our valuation checks. See what other red flags we found in the full valuation breakdown.

Approach 1: Aramark Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow model projects a company’s future cash flows and then discounts those back to today’s value to estimate what the business might be worth right now.

For Aramark, the model uses a 2 Stage Free Cash Flow to Equity approach. The latest twelve month Free Cash Flow is about $251.9 million. Analysts provide explicit Free Cash Flow estimates out to 2029, then Simply Wall St extrapolates further, with projected Free Cash Flow of $639 million in 2030. Additional projections extend through 2035, all expressed in $ and discounted back to today.

Adding these discounted cash flows together gives an estimated intrinsic value of about $31.68 per share. Compared with the recent share price of $44.95, the DCF output suggests the stock is 41.9% overvalued based purely on these cash flow assumptions.

This is a model driven result, but on these numbers alone, the current price sits well above the DCF estimate.

Result: OVERVALUED

Our Discounted Cash Flow (DCF) analysis suggests Aramark may be overvalued by 41.9%. Discover 51 high quality undervalued stocks or create your own screener to find better value opportunities.

Approach 2: Aramark Price vs Earnings

For a profitable company, the P/E ratio is a useful way to gauge how much you are paying for each dollar of earnings, which is often how the market anchors its view of value.

What counts as a reasonable P/E depends on what the market expects for future growth and how risky those earnings are. Higher expected growth and lower perceived risk can support a higher P/E, while lower growth or higher risk usually call for a lower multiple.

Aramark currently trades on a P/E of 37.28x. That is above the Hospitality industry average P/E of 21.58x and below the peer group average of 57.13x, so the stock sits between broader industry pricing and closer peers.

Simply Wall St’s Fair Ratio for Aramark is 28.80x. This is a proprietary estimate of what Aramark’s P/E might be given its earnings growth profile, industry, profit margins, market cap and specific risks. Because it incorporates these business fundamentals, the Fair Ratio aims to be more tailored than a simple comparison with peers or industry averages.

Comparing the Fair Ratio of 28.80x with the actual P/E of 37.28x suggests that Aramark currently trades above this fair value estimate.

Result: OVERVALUED

P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 18 top founder-led companies.

Upgrade Your Decision Making: Choose your Aramark Narrative

Earlier it was mentioned that there is an even better way to understand valuation. Think of a Narrative as your own clear story for Aramark that connects what you believe about its contracts, margins, and growth opportunities to a forecast for revenue, earnings, and cash flow, and then to a fair value that you can compare with the current price.

On Simply Wall St’s Community page, Narratives are an easy tool used by millions of investors. They allow you to plug in assumptions, see how that translates into a Fair Value estimate, and then quickly judge whether the current market price looks high or low relative to your view.

Narratives update automatically as new information arrives, such as contract wins like RWJ Barnabas Health, the Aramark Nexus agreement with a top global hyperscaler, or analyst revisions to revenue growth of 6.44%, profit margin of 3.13%, and a Fair Value of US$47.63. This helps ensure your story does not go stale when the data changes.

For Aramark, one investor might lean toward the higher analyst target of US$52.00 based on confidence in multi year contracts and international expansion. Another might anchor closer to US$35.00 due to concerns around labor costs, client concentration, and competition. Narratives make it simple to see how those different beliefs translate into different Fair Values relative to today’s price.

Do you think there's more to the story for Aramark? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.